Tardive blepharospasm associated with cinnarizine use.
OBJECTIVE
To report a patient with chronic blepharospasm possibly induced by the calcium-channel blocker cinnarizine.


METHODS
A 53-year-old woman developed chronic blepharospasm during a prolonged therapy with calcium-channel blocker cinnarizine for the treatment of vertigo.


CONCLUSIONS
"Tardive blepharospasm" should be considered as a possible adverse effect of cinnarizine.
Alonso-Navarro
Hortensia
H
Sección de Neurología, Hospital Virgen de la Concha, Zamora, and Departamento de Medicina-Neurología, Hospital Príncipe de Asturias, Universidad de Alcalá, Alcalá de Henares, Madrid, Spain.
Jiménez-Jiménez
Félix Javier
FJ
D001764:Blepharospasm / Q000139:chemically induced*; D002121:Calcium Channel Blockers / Q000009:adverse effects*; D002936:Cinnarizine / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008875:Middle Aged
D002121:Calcium Channel Blockers; D002936:Cinnarizine